Cargando…
Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France
BACKGROUND: The relative efficacy of a collar containing 10% imidacloprid and 4.5% flumethrin (Seresto®, Bayer HealthCare Animal Health) and a spot on formulation containing 10% imidacloprid and 2.5% moxidectin (Advocate®, Bayer HealthCare Animal Health) was evaluated as a control measure to prevent...
Autores principales: | Lechat, Charlotte, Siméon, Noémie, Pennant, Olivier, Desquilbet, Loïc, Chahory, Sabine, Le Sueur, Christophe, Guillot, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332727/ https://www.ncbi.nlm.nih.gov/pubmed/25884443 http://dx.doi.org/10.1186/s13071-015-0696-6 |
Ejemplares similares
-
Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats
por: Otranto, Domenico, et al.
Publicado: (2019) -
Prevention of canine ocular thelaziosis (Thelazia callipaeda) with a combination of milbemycin oxime and afoxolaner (Nexgard Spectra(®)) in endemic areas in France and Spain
por: Lebon, Wilfried, et al.
Publicado: (2019) -
Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio(®)) for the prevention of Thelazia callipaeda canine eyeworm infection
por: Bezerra-Santos, Marcos Antonio, et al.
Publicado: (2022) -
The spread of zoonotic Thelazia callipaeda in the Balkan area
por: Hodžić, Adnan, et al.
Publicado: (2014) -
Prevention of Thelazia callipaeda Reinfection among Humans
por: Trenkić, Marija, et al.
Publicado: (2023)